PLT group | CLD group | P | |
---|---|---|---|
Number of subjects | 33 | 25 | - |
Gender, M(%)-F(%) | 19 (58%) – 14 (41%) | 13 (51%) -12 (49%) | 0.79 |
Age (range, mean, sd) (years) | 6.2-18.0;12.8; sd ± 3.6 | 6.6-18.0; 11.9 yrs; sd ± 3.0 | 0.316 |
Age at transplantation (range, mean, sd) (years) | 0.2-12.5; 3.5; sd ± 3.7 | - | |
Avg time elapsed from PLT (mean, sd) (years) | 12.1; sd ± 4.3 | - | |
Average rate hospitalization (admissions/year) (mean, sd) | 7.9; sd ± 3.7 | Mean 2.9; sd ± 1.06 | 0.0001 |
Race (language) | Caucasian (Italian) | Caucasian (Italian) | |
Indications for liver transplant | Biliary atresia (n = 29); Metabolic liver disease (n = 2); Autoimmune hepatitis (n = 1); Hepatoblastoma (n = 1) | - | |
Type of chronic liver disease | - | Chronic viral or autoimmune hepatitis (n = 13); Wilson’s disease (n = 6); Cryptogenic chronic hepatopathy (n = 5); Others (n = 1). |